We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
{{ subpage.title }}
CRISPR gene editing and the human race
Berkeley scientist Jennifer Doudna won the 2020 Nobel Prize for her work on the revolutionary gene-editing technology known as CRISPR. It has the potential to cure genetic diseases like sickle cell anemia and hereditary blindness and may even be used to treat cancer and HIV. But when it comes to editing humanity, where do we draw the line? How do we avoid falling into the same kind of dystopian nightmare outlined in Blade Runner? Doudna discussed the risks and benefits of CRISPR in an interview with Ian Bremmer on GZERO World. Also in this episode: a look at cloning our pets (speaking of going too far…).
- CRISPR gene-editing tech should have limits, says Nobel laureate ... ›
- Podcast: Gene editing tech risks and rewards: Dr. Jennifer Doudna's ... ›
- Twitter bans QAnon; CRISPR gene tech - GZERO Media ›
- Ian Explains: Will biotech breakthroughs lead to super humans? - GZERO Media ›
- Podcast: Tracking the rapid rise of human-enhancing biotech with Siddhartha Mukherjee - GZERO Media ›
- From CRISPR to cloning: The science of new humans - GZERO Media ›
- CRISPR, AI, and cloning could transform the human race - GZERO Media ›
CRISPR gene-editing tech should have limits, says Nobel laureate Jennifer Doudna
For Jennifer Doudna, who won the 2020 Nobel Prize in Chemistry for her work on CRISPR gene editing, there are some red lines we shouldn't cross (yet). The technology, she says, has "the potential to do incredible things and make incredible advances that will be beneficial to our society, but hand-in-hand with that go these large risks." One is human embryos, but that doesn't mean that in the future we shouldn't be able to use CRISPR on ourselves, for instance to protect us from diseases. Watch her interview with Ian Bremmer on GZERO World.